NITROFURANTOIN | A201679 | AMNEAL PHARMACEUTICALS
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Macleods Pharmaceuticals Limited FDA-2018-P-0345 · 9 docket documents Macleods Pharmaceuticals Limited filed this citizen petition under Section 505(j) and 21 CFR 10.25(a), 10.30, and 314.93 requesting that FDA designate Amneal Pharms' approved ANDA #A201679 for Nitrofurantoin Oral Suspension, 25 mg/5 mL as a reference standard or identify a suitable alternative refer | Other | 2018-01-24 | Withdrawn | Macleods Pharmaceuticals Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$1.90
per ml
Lowest NADAC/Unit
$1.90
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69238251209NITROFURANTOIN 25 MG/5 ML SUSP | $1.90 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.